India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...

Ranked 35th, Eisai is the highest ranking among global pharmaceutical companies. Eisai was also the highest ranking among the 3 Japanese companies listed in the Global 100 (please visit here(New ...

The year 2024 was quite extraordinary, with Bitcoin achieving institutional acceptance as the SEC gave permission to launch a ...

More than 100 pharmaceutical ... Despite widespread risk, it’s clear that companies in the pharmaceutical supply chain are successfully leveraging an array of tools and strategies to mitigate ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry ... and less need for Indian exports. The companies are also concerned about what the impending appointment ...

Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

Taro Pharmaceuticals Inc, a subsidiary of Sun Pharmaceutical Industries Ltd has entered into an agreement with Canada’s Antibe Therapeutics Inc, to acquire 100 per cent in the company.

Promising a "simplification shock", the EU will unveil a much-anticipated blueprint to revamp Europe's economic model on ...

Amid intense criticism, UnitedHealth Group reported a $29 billion increase in 2024 revenues today, up 8% to $400.3 billion.

The CEO of the company whose insurance leader was killed in New York pledged to help fix the health care industry while also ...